Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
MGMT expression
Description:
The level of expression of O⁶-methylguanine-DNA methyltransferase, a DNA repair enzyme studied in cancer biology.
Primary topic:
Glioma Diagnosis and Treatment (43%)
Related topics:
Glioma Diagnosis and Treatment (43%),
Pituitary Gland Disorders and Treatments (7%),
DNA Repair Mechanisms (7%)
OpenAlex ID:
keywords/mgmt-expression
MGMT Status as a Clinical Biomarker in Glioblastoma
2020
·
Madison Butler
, Lorinc Pongor
, et al.
·
Trends in cancer
·
387
Targeted Modulation of MGMT: Clinical Implications
2006
·
Lili Liu
, Stanton L. Gerson
·
Clinical Cancer Research
·
272
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
2014
·
Julien Hadoux
, Judith Favier
, et al.
·
International Journal of Cancer
·
229
PDF
Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells.
1994
·
J.F. Costello
, B.W. Futscher
, et al.
·
Journal of Biological Chemistry
·
222
PDF
Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution
2013
·
Pei Yang
, Yongzhi Wang
, et al.
·
Journal of Neuro-Oncology
·
198
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
2016
·
M Cives
, M Ghayouri
, et al.
·
Endocrine Related Cancer
·
177
PDF
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
2018
·
Pamela L. Kunz
, Paul J. Catalano
, et al.
·
Journal of Clinical Oncology
·
176
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O 6 -Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
2010
·
Zachary M. Bush
, Janina A. Longtine
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
165
PDF
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
2012
·
Gérald Raverot
, Frédéric Castinetti
, et al.
·
Clinical Endocrinology
·
157
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors
2016
·
Pierre Bady
, Mauro Delorenzi
, et al.
·
Journal of Molecular Diagnostics
·
156
Temozolomide in the Era of Precision Medicine
2017
·
Anish Thomas
, Mamoru Tanaka
, et al.
·
Cancer Research
·
153
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
2011
·
Atsushi Sato
, Jun Sunayama
, et al.
·
Stem Cells
·
133
Treatment of pituitary neoplasms with temozolomide: A review
2010
·
Luis V. Syro
, Leon D. Ortiz
, et al.
·
Cancer
·
111
PDF
Molecular characteristics of serrated adenomas of the colorectum
2002
·
E J Sawyer
, A Cerar
, et al.
·
Gut
·
103
PDF
MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS -, and NF1 -Mutant Melanomas
2019
·
Ophélia Maertens
, Ryan Kuzmickas
, et al.
·
Cancer Discovery
·
101
PDF
Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
2007
·
Jonathon F. Parkinson
, Helen R. Wheeler
, et al.
·
Journal of Neuro-Oncology
·
101
Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
2010
·
Davide Sciuscio
, Annie-Claire Diserens
, et al.
·
Clinical Cancer Research
·
92
A specific CpG methylation pattern of theMGMT promoter region associated with reduced MGMT expression in primary colorectal cancers
1999
·
Klaus K.-F. Herfarth
, Thomas P. Brent
, et al.
·
Molecular Carcinogenesis
·
89
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma
2003
·
S Ma
, S Egyházi
, et al.
·
British Journal of Cancer
·
82
PDF
High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
2009
·
Akira Takeshita
, Naoko Inoshita
, et al.
·
European Journal of Endocrinology
·
77
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
2015
·
FENGMING LAN
, YANG YANG
, et al.
·
International Journal of Oncology
·
76
PDF
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
2017
·
Ke Wang
, Dongjiang Chen
, et al.
·
Cancer Cell International
·
71
PDF
Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas
2004
·
Satoshi Nakasu
, Tadateru Fukami
, et al.
·
Journal of Neuro-Oncology
·
69
Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines
2007
·
Jun Murakami
, You-Jin Lee
, et al.
·
Oncology Reports
·
68
PDF
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
2020
·
Hideaki Abe
, Manabu Natsumeda
, et al.
·
Frontiers in Oncology
·
66
PDF
Show more works
View as search
Works count:
287
Citation count:
6,034
Year
Topic
Type